Fresenius, Healthcare

Fresenius stock last traded at EUR 46.47 on September 28, 2026

Published on 09/28/2026 at 19:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius stock last traded at EUR 46.47 on September 28, 2026, up 0.68 percent. The company is reorganizing its hospital services business and has raised its 2026 outlook.

Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht
Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

Fresenius stock last traded at EUR 46.47 on September 28, 2026, on the Xetra market. The shares were up EUR 0.32, or 0.68 percent, from the previous session. The quote was timestamped at 15:35:29 UTC.

Hospital services reorganization

Fresenius said on September 16 that it will integrate the hospital services it provides internally for Helios into Helios Kliniken GmbH effective January 1, 2027. Around 1,700 of the more than 4,000 employees of Fresenius Health Services, together with their service companies, are expected to transfer to Helios. Fresenius Health Services will focus entirely on external clients, which the company said already account for around two-thirds of its revenue. Fresenius Investor Relations

Second-quarter highlights

Fresenius’ investor-relations materials list second-quarter 2026 consolidated revenue of EUR 5,864 million and EBIT of EUR 719 million, both before special items. Core net income was EUR 470 million and core earnings per share were EUR 0.83; the company states that these measures exclude Fresenius Medical Care and Vitrea. The materials also state that the 2026 outlook was raised.

Next reporting date

Fresenius lists November 4, 2026, as the publication date for its third-quarter financial report and related conference call. The event is scheduled to take place online. Fresenius Investor Relations

Disclaimer...

en | boerse | 70194204 |